Tuesday

25th Sep 2018

Thousands march in India against EU trade deal

  • Opponents of the deal say an EU request for a 'data exclusivity' clause will drive up the price of generic drugs made in India (Photo: e-Magine Art)

Thousands of HIV-positive protesters took to the streets in downtown New Delhi on Wednesday (2 March), concerned that an imminent EU-India free trade agreement (FTA) will end the production of affordable life-prolonging drugs.

The rally of more than 2,000 demonstrators from India and other Asian countries coincided with the re-start of sensitive trade negotiations in Brussels, with officials suggesting an end to the 2007-initiated talks is in sight.

Read and decide

Join EUobserver today

Support quality EU news

Get instant access to all articles — and 18 year's of archives. 30 days free trial.

... or join as a group

But opponents of the deal say an EU request for a 'data exclusivity' clause will drive the price of generic drugs made in India above an affordable level for people in poorer countries.

"More than 80 percent of the AIDS drugs our medical practitioners use to treat 175,000 people in developing countries are affordable generics from India," said Paul Cawthorne, a spokesman for Paris-based humanitarian group Medecins Sans Frontieres (MSF).

"Beyond AIDS, we rely on producers in India for drugs to treat other illnesses, such as tuberculosis and malaria. We cannot afford to let our patients lifeline be cut," Mr Cawthorne added, reports AFP.

Medicines have proved a sticking point in the ongoing discussions, with the EU keen to secure India's commitment to a strong intellectual property rights regime with respect to drugs.

European drug manufacturers complain that many of their patented products are frequently undercut by generics produced in India. EU customs officials have seized a number of containments bound for the 27-member state market over the past few years.

Until recently, Indian regulations allowed pharmaceutical companies to patent only drug-making processes and not the final products. Pressure from the World Trade Organisation has resulted in a tightening of those rules, but not as much as the EU would like.

Critics of the FTA say Europe's demand for 'data exclusivity' would mean that clinical trial data filed by one company could not be relied upon by other companies. As a result, the need for each firm to produce its own clinical trial tests would dramatically increase the price of medicines, they complain.

The United Nations is among those who also fear 'data exclusivity' provisions could act like a patent and block more affordable generic medicines from the market.

"It would be a colossal mistake to introduce data exclusivity in India, when millions of people across the globe depend on the country as the pharmacy of the developing world'," said Anand Grover, the UN Special Rapporteur on the Right to Health.

The EU is India's largest trading partner. Bilateral trade in goods and services between the two sides in 2009 was worth just under €69 billion, according to European Commission figures.

Another sensitive issue in the talks relates to the automobile sector, one of the subjects being discussed by commission and Indian negotiators this week. Here Europe is pushing for a reduction in Indian import tariffs on European cars, currently around 110 percent. Indian car manufacturers are against the move.

"We are aware of the position of the Indian car industry with respect to the negotiations," EU trade spokesman John Clancy told the Business Standard newspaper this week. "But it is clear that in order for the EU to support this agreement, access to India's car market must be improved significantly."

A compromise deal could revolve around the abolition of tariffs on high-end, luxury cars, while small models retain a degree of protection.

Opinion

Why are our medicines so expensive?

The EU should be promoting open innovation in upcoming trade talks with India and should work to bring down the prices of essential medicines, both abroad and within its borders.

EU court delivers transparency blow on MEP expenses

The General Court of the European Union in Luxembourg argued that disclosure of how MEPs use their monthly €4,400 expenses allowance risks violating an MEP's data protection rights. Journalists behind the case will appeal.

Investigation

Cyprus: Russia's EU weak link?

Five years and €10bn after its EU bailout, Cyprus is a weak link in Europe's banking system - amid renewed fears on Russia money-laundering.

Feature

Missing signature gaffe for Azerbaijan gas pipeline

A joint declaration on the Southern Gas Corridor project, which should deliver Azerbaijani gas to Europe by 2020, will remain secret - because the Turkish energy minister left before signing.

Visual Data

Every major city in Europe is getting warmer

An exclusive analysis of over 100 million meteorological data points shows that every major city in Europe is warmer in the 21s​t​ century than it was in the 20t​h​. Northern regions, Andalusia and southern Romania are most affected.

News in Brief

  1. UN chief: World suffering from 'trust deficit disorder'
  2. Stalemate in Sweden as parliament ousts prime minister
  3. Migrant rescue ship heading to French port
  4. EU angry at British tabloids on Brexit
  5. UK to allow EU flights in no-deal Brexit
  6. Greek reporters arrested after story on 'mishandled' EU funds
  7. Austrian minister urges police to out foreign sex offenders
  8. ECB's Draghi set to clarify role in secretive G30 group

EU court delivers transparency blow on MEP expenses

The General Court of the European Union in Luxembourg argued that disclosure of how MEPs use their monthly €4,400 expenses allowance risks violating an MEP's data protection rights. Journalists behind the case will appeal.

Agenda

Brexit and MEPs expenses in the spotlight This WEEK

The EU will be watching closely how the political dynamics of Theresa May's Conservative party conference starting next week will influence Brexit negotiations. MEPs might also be forced to release their office expenses.

Stakeholders' Highlights

  1. NORDIC COUNCIL OF MINISTERSThe vital bioeconomy. New issue of “Sustainable Growth the Nordic Way” out now
  2. NORDIC COUNCIL OF MINISTERSThe Nordic gender effect goes international
  3. NORDIC COUNCIL OF MINISTERSPaula Lehtomaki from Finland elected as the Council's first female Secretary General
  4. NORDIC COUNCIL OF MINISTERSNordic design sets the stage at COP24, running a competition for sustainable chairs.
  5. Counter BalanceIn Kenya, a motorway funded by the European Investment Bank runs over roadside dwellers
  6. ACCACompany Law Package: Making the Best of Digital and Cross Border Mobility,
  7. IPHRCivil Society Worried About Shortcomings in EU-Kyrgyzstan Human Rights Dialogue
  8. UNESDAThe European Soft Drinks Industry Supports over 1.7 Million Jobs
  9. Mission of China to the EUJointly Building Belt and Road Initiative Leads to a Better Future for All
  10. IPHRCivil society asks PACE to appoint Rapporteur to probe issue of political prisoners in Azerbaijan
  11. ACCASocial Mobility – How Can We Increase Opportunities Through Training and Education?
  12. Nordic Council of MinistersEnergy Solutions for a Greener Tomorrow

Latest News

  1. EU court delivers transparency blow on MEP expenses
  2. Russian with Malta passport in money-laundering probe
  3. Cyprus: Russia's EU weak link?
  4. Missing signature gaffe for Azerbaijan gas pipeline
  5. Every major city in Europe is getting warmer
  6. No chance of meeting EU renewable goals if infrastructure neglected
  7. Brexit and MEPs expenses in the spotlight This WEEK
  8. Wake-up call on European Day Against Islamophobia

Join EUobserver

Support quality EU news

Join us